 |
|
 |
| The evening
before the fourth Hanseatic India Colloquium. The speakers
and chairpersons
were invited by the organisers for a dinner. |
|
On Friday, 30
October 2009, the fourth Hanseatic India Colloquium started
with the Opening Session, chaired by Mr. Steffen Thormann,
Project Manager at the Hamburg Business Development Cooperation
(HWF). |
 |
|
 |
| The
Honourable Consul General of India in Hamburg, Dr. Vinod
Kumar, presented the opening address. |
|
Mr.
Bernd Reinert, State Secretary, Ministry of Science & Research
of Free and Hanseatic City of Hamburg, gave the
welcome address. |
 |
|
 |
| Dr.
Amal Mukhopadhyay, Founder and Director, ELGA Biotech, Hamburg,
and convenor of the Colloquium, was the chairman
of the first session on Biotechnology and Drug Development. |
|
Dr.
Siegfried Bialojan from Ernst & Young, Mannheim, gave
an overview of global trends in the Life Sciences Industry. |
 |
|
 |
| Dr.
Jens Würthner from GlaxoSmithKline,
Stevenage, UK, spoke about the opportunities and challenges
in emerging markets and developing countries. |
|
Dr.Ashok
Rattan, CEO, Fortis Clinical Research
Ltd., Faridabad
(Haryana) in INDIA described how India can help with multi-source
pharmaceutical products. |
 |
|
 |
| A
view of the audience |
|
Mr.
Sisir Gupta, COO at Venus Pharma GmbH in
Werne, Germany, and Chandigarh, India, gave a presentation
on generic formulation development: a Germany-India case
study.
|
 |
|
 |
| Mr.
Michael Anthony, Allianz
SE in Munich gave a special lecture on a pilot project of Allianz
in India. |
|
The
lunch-break gave the opportunity for a lot of interesting
discussions. |
 |
|
 |
| Prof Dr. Oliver
Rentzsch, CEO Medregio in Lübeck, was the chairman of
Session II on Phyto-Medicine. |
|
Dr. Sangeeta
Banerji, Research Associate of Plantachem, Berlin, described
the importance of Indian medicinal plants in drug development. |
 |
|
 |
| Dr. Mrutyunjay
Suar, Director & Head, KIIT School of Biotechnology,
Bhubaneswar, India, gave an insight into the future prospects
of herbal biotechnology. |
|
Mrs. Anuradha
Acharya, Founder & CEO, Ocimum Biosolutions, Hyderabad,
chaired Session III on Technology Cooperation in R&D. |
 |
|
 |
| Mr.
Sanjay Bettadpura, Chief Business Development Officer,
Polyclone Bioservices Pvt. Ltd., Bangalore, India, presented
partnering models for effective molecular assay design
and validation. |
|
Dr.
Michael Piontek, Managing Director of ARTES Biotechnology,
Langenfeld, described Indo-German cooperation in technology
transfer in the field of biosimilars. |
 |
|
 |
| Dr.
Klaus Maleck, CFO, Evotec, Hamburg, gave an insight into the
benefit of the combination of European and Indian research
groups at Evotec. |
|
Mr.
Florian Grabow, Werum Software & Systems, Lüneburg,
reported on their experiences in India with respect to
bringing pharmaceutical compliance to pharmaceutical companies. |
 |
|
 |
| Talking and
networking |
|
Dr. Thomas Kolzau,
Head of Business Development, IPB AG in Hamburg, was the
chairman of Session IV on intellectual property and its relevance
to Indo-European business. |
 |
|
 |
| A view of the
audience |
|
Dr.
Ralf D. Kirsch, Biologist and Patent Attorney, GLAWE DELFS
MOLL, Hamburg, gave an insight into the recent trends in European
patenting and the relevance to Indian applicants. |
 |
|
 |
| Mr. Hans Kuhn,
Head of Life Science Projects, NORGENTA, contributing to the
discussion. |
|
Co-organizers
of the Colloquium, Mr. Dieter
Grützmacher and Dr. Amal K. Mukhopadhyay. |
 |
|
 |
| Mrs.
Sunita Sreedharan, Patent Attorney, Chief Executive Officer,
SKS Law Associates, New Delhi, spoke about recent trends in
the Indian patent law. |
|
Mrs.
Viveka Roychowdhury, Editorial Head, Express Pharma, Indian
Express Newspapers (Mumbai) Ltd., Mumbai, gave a lecture on
the role of media in the growth of Life Sciences Industry
in India. |
 |
|
 |
| Finally the
fourth Hanseatic India Colloquium came to a happy end at
the Hotel Hafen Hamburg... |
|
...with an excellent
meal. |
 |
|
 |
| |
|
|
